Bentham Science Logo

Most Accessed Articles


Sodium-glucose Cotransporter 2 Inhibitors: The Impact on Development and Progression of Heart Failure

, 2018; 18(2): 127-133.

Vasilios Papademetriou* and Eleni Geladari


DOI: 10.2174/1871529X18666180405102658


Sodium-glucose Cotransporter 2 Inhibitors: Glucose Lowering Against other Hypoglycemic Agents

, 2018; 18(2): 94-103.

Konstantinos Avranas*, Konstantinos Imprialos, Konstantinos Stavropoulos, Georgios Lales, Alexandos Manafis, Anastasia Skalkou and Lars Kihm


DOI: 10.2174/1871529X18666180206160838


The Endocannabinoid System and Heart Disease: The Role of Cannabinoid Receptor Type 2

, 2018; 18(1): 34-51.

Makenzie L. Fulmer and Douglas P. Thewke*


DOI: 10.2174/1871529X18666180206161457


Sodium-glucose Cotransporter 2 Inhibitors and the Risk of Diabetic Ketoacidosis; from Pathophysiology to Clinical Practice

, 2018; 18(2): 139-146.

Dimitrios Patoulias*, Alexandros Manafis, Christos Mitas, Konstantinos Avranas, Georgios Lales, Ioanna Zografou, Christos Sambanis and Asterios Karagiannis


DOI: 10.2174/1871529X18666180206123149


Berberine Encapsulated PLGA-PEG Nanoparticles Modulate PCSK-9 in HepG2 Cells

, 2018; 18(1): 61-70.

Chinedu C. Ochin and Mahdi Garelnabi*


DOI: 10.2174/1871529X18666180201130340


Acute Myeloid Leukemia: Diagnosis and Management Based on Current Molecular Genetics Approach

, 2018; 18(3): 199-207.

Elumalai Suguna*, Rahman Farhana, Elangovan Kanimozhi, Pindigiri Sai Kumar, Govindasamy Kumaramanickavel and Chitralekha Sai Kumar


DOI: 10.2174/1871529X18666180515130136


Sodium-glucose Cotransporter 2 Inhibitors: Nephroprotective Impact on Diabetic Kidney Disease

, 2018; 18(2): 120-126.

Konstantinos Stavropoulos*, Konstantinos P. Imprialos, Nikiforos Stavropoulos, Sofia Bouloukou, Georgios Kerpiniotis, Kyriakos Dimitriadis, Constantinos Tsioufis and Michael Doumas


DOI: 10.2174/1871529X18666180206155349




Webmaster Contact: info@benthamscience.org
Copyright © 2018 Bentham Science